Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein coupled receptors(GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is based in Watertown, Massachusetts. more
Time Frame | TECX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 4.65% | -2.12% | -3% |
1-Month Return | 7.74% | -3.42% | -0.73% |
3-Month Return | 136.25% | -11.13% | 2.87% |
6-Month Return | 3953233.33% | -5.74% | 7.17% |
1-Year Return | 3953233.33% | 3.97% | 25.31% |
3-Year Return | 1976566.67% | 1.05% | 28.38% |
5-Year Return | 3953233.33% | 34.37% | 81.89% |
10-Year Return | 3953233.33% | 97.88% | 183.27% |
Dec '20 | Dec '21 | Dec '22 | Dec '23 | |||
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Cost of Revenue | 1.21M | 1.40M | 4.17M | 617.00K | [{"date":"2020-12-31","value":28.97,"profit":true},{"date":"2021-12-31","value":33.58,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":14.81,"profit":true}] | |
Gross Profit | (1.21M) | (1.40M) | (4.17M) | (617.00K) | [{"date":"2020-12-31","value":-120700000,"profit":false},{"date":"2021-12-31","value":-139900000,"profit":false},{"date":"2022-12-31","value":-416600000,"profit":false},{"date":"2023-12-31","value":-61700000,"profit":false}] | |
Gross Margin | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Operating Expenses | 119.02M | 117.44M | 101.27M | 44.65M | [{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":98.67,"profit":true},{"date":"2022-12-31","value":85.08,"profit":true},{"date":"2023-12-31","value":37.51,"profit":true}] | |
Operating Income | (120.23M) | (118.84M) | (105.43M) | (44.65M) | [{"date":"2020-12-31","value":-12022800000,"profit":false},{"date":"2021-12-31","value":-11884100000,"profit":false},{"date":"2022-12-31","value":-10543400000,"profit":false},{"date":"2023-12-31","value":-4464800000,"profit":false}] | |
Total Non-Operating Income/Expense | - | (103.96M) | (73.06M) | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-10396100000,"profit":false},{"date":"2022-12-31","value":-7305500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] | |
Pre-Tax Income | (119.71M) | (119.13M) | (105.89M) | (42.82M) | [{"date":"2020-12-31","value":-11971200000,"profit":false},{"date":"2021-12-31","value":-11912600000,"profit":false},{"date":"2022-12-31","value":-10589000000,"profit":false},{"date":"2023-12-31","value":-4282300000,"profit":false}] | |
Income Taxes | - | - | - | 377.00K | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}] | |
Income After Taxes | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Income From Continuous Operations | - | (8.93M) | (32.18M) | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-892700000,"profit":false},{"date":"2022-12-31","value":-3218000000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] | |
Income From Discontinued Operations | - | - | - | - | [{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] | |
Net Income | (119.71M) | (119.13M) | (105.89M) | (42.82M) | [{"date":"2020-12-31","value":-11971200000,"profit":false},{"date":"2021-12-31","value":-11912600000,"profit":false},{"date":"2022-12-31","value":-10589000000,"profit":false},{"date":"2023-12-31","value":-4282300000,"profit":false}] | |
EPS (Diluted) | (39.71) | (25.23) | (29.05) | 3.81 | [{"date":"2020-12-31","value":-1043.61,"profit":false},{"date":"2021-12-31","value":-662.93,"profit":false},{"date":"2022-12-31","value":-763.55,"profit":false},{"date":"2023-12-31","value":100,"profit":true}] | |
These ratios help you determine the liquidity of the company. Higher is better.
TECX | |
---|---|
Cash Ratio | 9.19 |
Current Ratio | 9.39 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TECX | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TECX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.11 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.89 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TECX | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 1.59 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Tectonic Therapeutic, Inc. (TECX) share price today is $47.44
Yes, Indians can buy shares of Tectonic Therapeutic, Inc. (TECX) on Vested. To buy Tectonic Therapeutic, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TECX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Tectonic Therapeutic, Inc. (TECX) via the Vested app. You can start investing in Tectonic Therapeutic, Inc. (TECX) with a minimum investment of $1.
You can invest in shares of Tectonic Therapeutic, Inc. (TECX) via Vested in three simple steps:
The 52-week high price of Tectonic Therapeutic, Inc. (TECX) is $53.34. The 52-week low price of Tectonic Therapeutic, Inc. (TECX) is $0.
The price-to-earnings (P/E) ratio of Tectonic Therapeutic, Inc. (TECX) is
The price-to-book (P/B) ratio of Tectonic Therapeutic, Inc. (TECX) is 1.59
The dividend yield of Tectonic Therapeutic, Inc. (TECX) is 0.00%
The market capitalization of Tectonic Therapeutic, Inc. (TECX) is $265.07M
The stock symbol (or ticker) of Tectonic Therapeutic, Inc. is TECX